(Q43039391)

12 November 2017

title

Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil (English)

1 reference

12 November 2017

1 reference

1 reference

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

chronic liver disease

0 references

author name string

Fernanda Branco

1

1 reference

12 November 2017

Angelo Alves de Mattos

2

1 reference

12 November 2017

Gabriela Perdomo Coral

3

1 reference

12 November 2017

Bart Vanderborght

4

1 reference

12 November 2017

Diogo Edele Santos

5

1 reference

12 November 2017

Paulo França

6

1 reference

12 November 2017

Cláudio Alexandre

7

1 reference

12 November 2017

publication date

1 January 2007

1 reference

Arquivos de Gastroenterologia

12 November 2017

published in

1 reference

12 November 2017

volume

44

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

58-63

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Lamivudine resistant occult HBV: implications for public health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Occult hepatitis B virus infection and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Long-term clinical impact of occult hepatitis B virus infection in chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Hepatocellular carcinoma: present status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Standardization of hepatitis C virus RNA quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032007000100013

10.1590/S0004-28032007000100013

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference